Global Rheumatoid Arthritis Drug Market Outlook 2022 - Boosted by the Increasing Number of Patients with Rheumatoid Arthritis - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Rheumatoid Arthritis Drug Market Outlook 2022" report to their offering.

Therapeutic advances have transformed the rheumatoid arthritis treatment paradigm over the last 20 years, from focusing on symptom management to now aiming for slowed disease progression and even disease remission. Disease-modifying biological medicines have ushered in a new age of treatment by targeting the cells involved in the progression of the disease.

These medicines have dramatically slowed or even reversed the negative physical effects associated with the disease and made clinical remission possible for patients with severe rheumatoid arthritis. The market of anti-rheumatics is growing at a constant speed globally. There are some driving factors which are accelerating the growth of anti-rheumatics market such as the increasing number of patients with rheumatoid arthritis, rise in research and development activities, increasing awareness among people about rheumatoid arthritis, and improved healthcare infrastructure in the region.

Until late in the 20th century, the therapy of rheumatic diseases relied on the use of drugs that had been developed through empirical approaches without detailed understanding of the molecular mechanisms involved. That approach changed with the introduction of biologic therapeutics at the end of the 20th century and by the recent development of small-molecule inhibitors of intracellular signal transduction pathways.

Companies Mentioned

  • Abbvie
  • Biogen Idec
  • Bristol-Myers Squibb
  • Celgene
  • Celltrion
  • J&J
  • MedImmune
  • Merck
  • Novartis
  • Takeda

Key Topics Covered:

1. Antirheumatoids: Call of Rheumatoid Arthritis

2. Molecular Mechanism of Antirheumatoids

3. Classification of Rheumatoid Arthritis Drugs

4. Synthetic DMARDs as Rheumatoid Arthritis Drug

5. Biological Agents as Rheumatoid Arthritis Drug

6. Global Prevalence of Rheumatoid Arthritis

7. Global Tendencies in Use of Antirheumatics

8. Global Market of Rheumatoid Arthritis Drug

9. Global Rheumatoid Arthritis DrugMarket Dynamics

10. Global Rheumatoid Arthritis Drug Market Future Prospect

11. Competitive Landscape

For more information about this report visit http://www.researchandmarkets.com/research/n67qp7/global_rheumatoid

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Immune Disorders Drugs, Musculoskeletal Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Immune Disorders Drugs, Immune Disorders Drugs, Musculoskeletal Disorders Drugs